文献速递肝病

PNPLA3 rs738409与NAFLD纤维化风险:通过中间组织学特征探索中介通路

PNPLA3 rs738409 and risk of fibrosis in NAFLD: Exploring mediation pathways through intermediate histological features.
PubMed 文献 · Hepatology · 2022-04-21

研究在1153例经活检证实的非西班牙裔白人NAFLD患者中,用因果中介模型分析rs738409对纤维化严重程度的总效应、直接效应及经组织学特征的中介效应,并在404例其他种族患者中重复。结果显示总效应β=0.19,直接效应β=0.09,间接效应β=0.010;门管区炎症中介效应最大(β=0.09),小叶炎症后接气球样变的序列路径间接效应最显著(β=0.023)。结论认为rs738409对纤维化严重程度的总效应近半由直接通路解释,提示其可能通过激活特定致纤维化通路促进纤维化。

要点

  • 在1153例经活检证实的非西班牙裔白人NAFLD患者中,rs738409对纤维化严重程度的总效应β=0.19(95%CI 0.09-0.29)。
  • 去除中介因素后直接效应β=0.09(95%CI 0.01-0.17),提示近半总效应由直接通路解释。
  • 门管区炎症中介效应最大(β=0.09,95%CI 0.05-0.12)。

核心结论

  • 在NAFLD中,rs738409 G等位基因对纤维化严重程度的总效应近半可由直接通路解释,提示rs738409可能通过激活特定致纤维化通路促进纤维化。
  • rs738409对纤维化严重程度间接效应的很大比例由门管区炎症介导。

研究设计与样本

  • 因果中介模型(多个中介变量平行或序列纳入),分析1153例经活检证实的非西班牙裔白人NAFLD患者。
  • 另在404例其他种族和族裔的经活检证实NAFLD患者中重复中介分析。

主要发现

  • rs738409对纤维化的总效应β=0.19(95%CI 0.09-0.29)。
  • 去除中介因素效应后rs738409对纤维化的直接效应β=0.09(95%CI 0.01-0.17),经全部中介因素的间接效应β=0.010(95%CI 0.04-0.15)。
  • 所有中介变量中效应量最大者为门管区炎症(β=0.09,95%CI 0.05-0.12)。
  • 不同组织学特征序列组合中,小叶炎症后接气球样变路径的间接效应最显著(β=0.023,95%CI 0.011-0.037)。
  • 在404例其他种族和族裔的经活检证实NAFLD患者中,中介分析显示相似结果。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: It is unclear whether rs738409 (p.I148M) missense variant in patatin-like phospholipase domain-containing 3 rs738409 promotes fibrosis development by triggering specific fibrogenic pathways or by creating an unfavorable microenvironment by promoting steatosis, inflammation, and ultimately fibrosis. We tested the hypothesis that intermediate histologic traits, including steatosis, lobular and portal inflammation, and ballooning may determine the effect of rs738409 on liver fibrosis among individuals with biopsy-proven NAFLD. APPROACH AND RESULTS: Causal mediation models including multiple mediators in parallel or sequentially were performed to examine the effect of rs738409, by decomposing its total effect on fibrosis severity into direct and indirect effects, mediated by histology traits in 1153 non-Hispanic White patients. Total effect of rs738409 on fibrosis was β = 0.19 (95% CI: 0.09-0.29). The direct effect of rs738409 on fibrosis after removing mediators' effects was β = 0.09 (95% CI: 0.01-0.17) and the indirect effect of rs738409 on fibrosis through all mediators' effects were β = 0.010 (95% CI: 0.04-0.15). Among all mediators, the greatest estimated effect size was displayed by portal inflammation (β = 0.09, 95% CI: 0.05-0.12). Among different sequential combinations of histology traits, the path including lobular inflammation followed by ballooning degeneration displayed the most significant indirect effect (β = 0.023, 95% CI: 0.011-0.037). Mediation analysis in a separate group of 404 individuals with biopsy-proven NAFLD from other races and ethnicity showed similar results. CONCLUSIONS: In NAFLD, nearly half of the total effect of the rs738409 G allele on fibrosis severity could be explained by a direct pathway, suggesting that rs738409 may promote fibrosis development by activating specific fibrogenic pathways. A large proportion of the indirect effect of rs738409 on fibrosis severity is mediated through portal inflammation.

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Vilar-Gomez E, Pirola CJ, Sookoian S, et al. PNPLA3 rs738409 and risk of fibrosis in NAFLD: Exploring mediation pathways through intermediate histological features. Hepatology. 2022. PMID: 35349726. doi:10.1002/hep.32491

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。